生命科学资讯

Boston Scientific claims European approval for Farapoint focal pulsed field ablation catheter

CDER head Richard Pazdur set to retire shortly after appointment

FDA to remove some monkey testing from monoclonal antibody development

Richard Pazdur, FDA drug czar, to retire from agency

Thermo Fisher Scientific (TMO) Stock on December 2, 2025: Price Action, HSBC Upgrade, New Debt Deal and 2026–2030 Forecasts - ts2.tech

Tech emerges as a new frontier for digital therapeutics

FDA details plan to scale back animal tests for some antibody drugs

In the clinic for Dec. 2, 2025

Other news to note for Dec. 2, 2025

Regulatory actions for Dec. 2, 2025

US pediatric voucher making moves in Congress

More uncertainty at FDA as Pazdur plans to resign

Hightide’s HTD-1801 outperforms Farxiga in type 2 diabetes

Subcutaneous biologics maker Bao Pharma prices $128M IPO

10x Genomics Comments on Second UPC Preliminary Injunction Decis - GuruFocus

ARCH, Parker Institute build next big oncology bet with suite of programs and startup acquisition

Top drug regulator Rick Pazdur plans to leave FDA

An archaeal transcription factor bridges prokaryotic and eukaryotic regulatory paradigms

Imvax takes brain cancer cell therapy to FDA, betting survival hit will overshadow primary miss

Tiziana to spin out IL-6 drug into new company, citing Big Pharma's interest in modality